Avant Bio
Avant Bio is a venture capital investor based in New York, United States. It reports about $56m in private-fund assets across 1 private fund to the US Securities and Exchange Commission (Form ADV, October 2026). Its funds raised about $57m in the last 36 months (Form D filings).
Part of the 311 Institute Global Investors Directory (311institute.com). Last updated .
Other investors in United States
- New Mountain Capital
- Sixth Street
- Blackstone Life Sciences
- Macquarie Infrastructure Partners
- H.I.G. Capital
- Comvest Credit
- Court Square Capital
- Hamilton Lane
- Peak Rock Capital
- TPG Solutions
- Patient Square Capital
- Kleiner Perkins
Related
- Innovation profile of New York
- United States: economy and key statistics
- Global Startups Directory
- All 311 Indexes
Questions and answers
What kind of investor is Avant Bio?
Avant Bio is a venture capital investor based in New York, United States.
Where is Avant Bio based?
Avant Bio is headquartered in New York, United States, according to its filing with the US Securities and Exchange Commission.
How much does Avant Bio manage?
It reports about $56m in private-fund assets across 1 private fund to the US Securities and Exchange Commission (Form ADV, October 2026).
Source: US Securities and Exchange Commission adviser record (Form ADV and Form D filings), as of October 2026.
© 311 Institute 2026. Facts from the sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.